Company
United StatesPublic company, NYSE: DGXQuest Diagnostics Inc. (NYSE: DGX), Toa Baja, PR – FDA Inspections
Inspection records and compliance data for Quest Diagnostics Inc. in Toa Baja, Puerto Rico. 2 FDA inspections on record, last inspected July 09, 2013. Publicly traded as NYSE: DGX.
Company Profile
This profile covers Quest Diagnostics Inc. based in Toa Baja, Puerto Rico, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 4, 2011. Last inspected July 9, 2013.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 9, 2013 | NAI | Biologics · Blood and Blood Products | 839625 |
| May 4, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 727078 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Quest Diagnostics Inc.
Stock ticker
DGX
Exchange
NYSE
Share price
$254.20
Market cap
$28.0B
Price as of
November 6, 2026
FEI Number
1000110320
Address
210 Carr 865, Toa Baja, Puerto Rico 00949, United States
Country
United States
ID: 4a3e8d09-5d01-4dab-a379-2c572fa68c47